Computational Drug Design Study of Curcuma longa L. Compound as HPV-16 Antiviral Candidate Against Cervical Cancer

https://doi.org/10.24036/sainstek/vol1-iss01/2

Authors

  • Sin War Naw Department of Chemistry, Myitkyina University, Myitkyina, Myanmar
  • Rasyadan Taufiq Probojati Department of Agrotechnology, Faculty of Agriculture, Universitas Kadiri, Kediri, Indonesia
  • Ahmad Affan Ali Murtadlo Computational Virology Research Unit, Division of Molecular Biology and Genetics, Generasi Biologi Indonesia Foundation, Gresik, Indonesia
  • Md. Emdad Ullah Department of Chemistry, Mississippi State University, Mississippi State, United States

Keywords:

Antiviral, Bioinformatics, Curcuma longa, HPV

Abstract

Human papillomavirus (HPV) is one of the causes of cervical cancer in women. These viruses have DNA-type genetic material, are not enveloped, and are divided into two types based on their ability to trigger cancer. High-risk HPV is the type of HPV that often causes cervical cancer cases, this is due to the high expression of oncoprotein E6. E6 works through the inhibition and degradation of p53 to trigger cancer. HPV drugs tend to be expensive and must use alternative solutions such as the herbal Curcuma longa L. Curcuma longa L. is an herbal plant that is widely used by the public for their daily needs, for example as an antiviral, antioxidant, and anti-inflammatory. This study aims to predict the molecular mechanism and screening of drug candidate compounds in Curcuma longa L. to inhibit the activity of the HPV E6 protein through a bioinformatics approach. This study used in silico methods such as docking simulations and molecular interaction analysis to identify potential antiviral candidate compounds. Curcuma longa L. can act as an antiviral through the binding activity of Curcumin compounds in preventing the E6-p53 complex through the specific domains and stable because it have a many number of hydrogen bonds. We recommend the E6-binding domain for further research as a target for HPV drug design and the results of this study are yet to be verified through wet lab testing

References

Liu Y, Pan Y, Gao W, Ke Y, Lu Z. Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women. Sci Rep. 2017; 7(1): 263. doi: 10.1038/s41598-017-00364-9.

Hirose Y, Onuki M, Tenjimbayashi Y, Yamaguchi-Naka M, Mori S, Tasaka N, Satoh T, Morisada T, Iwata T, Kiyono T, Mimura T, Sekizawa A, Matsumoto K, Kukimoto I. Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions. Viruses. 2019; 11(4):350. doi: 10.3390/v11040350.

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 2018; 516:86-101. doi: 10.1016/j.virol.2018.01.002.

Travé G, Zanier K. HPV-mediated inactivation of tumor suppressor p53. Cell Cycle. 2016; 15(17):2231-2. doi: 10.1080/15384101.2016.1191257.

Jennings MR, Parks RJ. Curcumin as an Antiviral Agent. Viruses. 2020; 12(11):1242. doi: 10.3390/v12111242.

Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakrishnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon. 2021; 7(2):e06350. doi: 10.1016/j.heliyon.2021.e06350.

Abdel-Lateef E, Mahmoud F, Hammam O, El-Ahwany E, El-Wakil E, Kandil S, Abu Taleb H, El-Sayed M, Hassenein H. Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2). Acta Pharm. 2016; 66(3):387-98. doi: 10.1515/acph-2016-0028.

Ansori ANM, Fadholly A, Hayaza S, Susilo RJK, Inayatillah B, Winarni D, Husen SA. A Review on Medicinal Properties of Mangosteen (Garcinia mangostana L.). Res J Pharm Techol. 2020; 13(2):974-982. doi: 10.5958/0974-360X.2020.00182.1.

Husen SA, Wahyuningsih SPA, Ansori ANM, Hayaza S, Susilo RJK, Winarni D, Punnapayak H, Darmanto W. Antioxidant Potency of Okra (Abelmoschus esculentus Moench) Pods Extract on SOD Level and Tissue Glucose Tolerance in Diabetic Mice. Res J Pharm Technol. 12(12): 5683. doi: 10.5958/0974-360X.2019.00983.1.

Husen SA, Setyawan MF, Syadzha MF, Susilo RJK, Hayaza S, Ansori ANM, Alamsjah MA, Ilmi ZN, Wulandari PAC, Pudjiastuti P, Awang P, Winarni D. A Novel Therapeutic effects of Sargassum ilicifolium Alginate and Okra (Abelmoschus esculentus) Pods extracts on Open wound healing process in Diabetic Mice. Research J. Pharm. and Tech 2020; 13(6): 2764-2770. doi: 10.5958/0974-360X.2020.00491.6.

Kharisma VD, Kharisma SD, Ansori ANM, Kurniawan HP, Witaningrum AM, Fadholly A, Tacharina MR. Antiretroviral Effect Simulation from Black Tea (Camellia sinensis) via Dual Inhibitors Mechanism in HIV-1 and its Social Perspective in Indonesia. Res J Pharm Technol. 2021; 14(1): 455-460. doi: 10.5958/0974-360X.2021.00083.4.

Fadholly A, Ansori ANM, Kharisma VD, Rahmahani J, Tacharina MR. Immunobioinformatics of Rabies Virus in Various Countries of Asia: Glycoprotein Gene. Res J Pharm Technol. 2021; 14(2): 883-886. doi: 10.5958/0974-360X.2021.00157.8.

Ansori ANM, Fadholly A, Proboningrat A, Hayaza S, Susilo RJK, Naw SW, Posa GAV, Yusrizal YF, Sibero MT, Sucipto TH, Soegijanto S. In vitro antiviral activity of Pinus merkusii (Pinaceae) stem bark and cone against dengue virus type-2 (DENV-2). Res J Pharm Technol. 2021; 14(7):3705-8. doi: 10.52711/0974-360X.2021.00641.

Ansori ANM, Kharisma VD, Fadholly A, Tacharina MR, Antonius Y, Parikesit AA. Severe Acute Respiratory Syndrome Coronavirus-2 Emergence and Its Treatment with Alternative Medicines: A Review. Res J Pharm Technol. 2021; 14(10):5551-7. doi: 10.52711/0974-360X.2021.00967

Husen SA, Ansori ANM, Hayaza S, Susilo RJK, Zuraidah AA, Winarni D, Punnapayak H, Darmanto W. Therapeutic Effect of Okra (Abelmoschus esculentus Moench) Pods Extract on Streptozotocin-Induced Type-2 Diabetic Mice. Res J Pharm Technol. 2019; 12(8):3703-3708. doi: 10.5958/0974-360X.2019.00633.4.

Ansori ANM, Kharisma VD, Solikhah TI. Medicinal properties of Muntingia calabura L.: A Review. Res J Pharm Technol. 2021; 14(8):4509-2. doi: 10.52711/0974-360X.2021.00784.

Proboningrat A, Kharisma VD, Ansori ANM, Rahmawati R, Fadholly A, Posa GAV, Sudjarwo SA, Rantam FA, Achmad AB. In silico Study of Natural inhibitors for Human papillomavirus-18 E6 protein. Res J Pharm Technol. 2022; 15(3):1251-6. doi: 10.52711/0974-360X.2022.00209.

Fahmi M, Kharisma VD, Ansori ANM, M Ito. Retrieval and Investigation of Data on SARS-CoV-2 and COVID-19 Using Bioinformatics Approach. Adv Exp Med Biol. 2021; 1318: 839-857. doi: 10.1007/978-3-030-63761-3_47.

Kharisma VD, Agatha A, Ansori ANM, Widyananda MH, Rizky WC, Dings TGA, Derkho M, Lykasova I, Antonius Y, Rosadi I, Zainul R. Herbal combination from Moringa oleifera Lam. and Curcuma longa L. as SARS-CoV-2 antiviral via dual inhibitor pathway: A viroinformatics approach. J Pharm Pharmacogn Res. 2022; 10(1): 138-146.

Luqman A, Kharisma VD, Ruiz RA, Götz F. In Silico and in Vitro Study of Trace Amines (TA) and Dopamine (DOP) Interaction with Human Alpha 1-Adrenergic Receptor and the Bacterial Adrenergic Receptor QseC. Cell Physiol Biochem. 2020; 54: 888-898. doi: 10.33594/000000276.

Nugraha AP, Rahmadhani D, Puspitaningrum MS, Rizqianti Y, Kharisma VD, Ernawati DS. Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy. J Adv Pharm Technol Res. 2021; 12 (4): 362-367. doi: 10.4103/japtr.japtr_126_21.

Wijaya RM, Hafidzhah MA, Kharisma VD, Ansori ANM, Parikesit AA. COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein. Makara J Sci. 2021; 25(3): 162-171. doi: 10.7454/mss.v25i3.1244.

Prahasanti C, Nugraha AP, Kharisma VD, Ansori ANM, Devijanti R, Ridwan TPSP, Ramadhani NF, Narmada IB, Ardani IGAW, Noor TNEBA. A bioinformatic approach of hydroxyapatite and polymethylmethacrylate composite exploration as dental implant biomaterial. J Pharm & Pharmacogn Res. 2021; 9(5): 746-754.

Susanto H, Kharisma VD, Listyorini D, Taufiq A. Effectivity of Black Tea Polyphenol in Adipogenesis Related IGF-1 and Its Receptor Pathway Through In Silico Based Study. J Phys Conf Ser. 2019; 1093 (1): 012037.

Ansori ANM, Kharisma VD, Parikesit AA, Dian FA, Probojati RT, Rebezov M, Scherbakov P, Burkov P, Zhdanova G, Mikhalev A, Antonius Y, Pratama MRF, Sumantri NI, Sucipto TH, Zainul R. Bioactive Compounds from Mangosteen (Gracinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARS-CoV-2: An In Silico Approach. Pharmacogn J. 2022; 14(1): 85-90. doi: 10.5530/pj.2022.14.12.

Dibha AF, Wahyuningsih S, Kharisma VD, Ansori ANM, Widyananda, MH, Parikesit AA, Rebezov M, Matrosova Y, Artyukhova S, Kenijz N, Kiseleva M, Jakhmola V, Zainul R. Biological activity of kencur (Kaempferia galanga L.) against SARS-CoV-2 main protease: In silico study. Int J Health Sci. 2022; 6(S1): 468-480. doi: 10.53730/ijhs.v6nS1.4779.

Ramadhani NF, Nugraha AP, Rahmadhani D, Puspitaningrum MS, Rizqianti Y, Kharisma VD, Noor TNEBTA, Ridwan RD, Ernawati DS, Nugraha AP. Anthocyanin, tartaric acid, ascorbic acid of roselle flower (Hibiscus sabdariffa L.) for immunomodulatory adjuvant therapy in oral manifestation coronavirus disease-19: An immunoinformatic approach. J Pharm Pharmacogn Res. 2022; 10(3): 418-428.

Hartati FK, Djauhari AB, Kharisma VD. Evaluation of Pharmacokinetic Properties, Toxicity, and Bioactive Cytotoxic Activity of Black Rice (Oryza sativa L.) as Candidates for Diabetes Mellitus Drugs by in silico. Biointerface Res App Chem. 2021; 11(4): 12301-12311. doi: 10.33263/BRIAC114.1230112311.

Kharisma VD, Ansori ANM, Fadholly A, Sucipto TH. Molecular Mechanism of Caffeine-Aspirin Interaction in Kopi Balur 1 as Anti-Inflammatory Agent: A Computational Study. Indian J Forensic Med Tox. 2020; 14(4): 4041-4046.

Published

2022-06-09

How to Cite

Naw, S. W. ., Probojati, R. T. ., Murtadlo, A. A. A. ., & Ullah, M. E. . (2022). Computational Drug Design Study of Curcuma longa L. Compound as HPV-16 Antiviral Candidate Against Cervical Cancer. SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics, 1(01), 1–6. https://doi.org/10.24036/sainstek/vol1-iss01/2

Most read articles by the same author(s)